Skip to main content
. 2024 Oct 10;5:42. doi: 10.1186/s43556-024-00207-w

Fig. 3.

Fig. 3

JAK/STAT signaling pathway can be activated or inhibited by inflammatory cytokines to regulate the inflammation of UC. The JAK family (JAK1, JAK2, JAK3, TYK2) binds non-covalently to cytokine receptors, and STATs, as JAK substrates, interact with the tyrosine phosphorylation signaling pathway. JAKs can interact with multiple STATs, which act as the final effectors of signaling, and these combinations can be activated to regulate transcription. Cytokines, including IL-6, IL-12, IL-23, and IL-27, activate the JAK/STAT signaling pathway via the JAK family, regulating the release of Th and Treg cells, thereby influencing UC inflammation. ‘Adapted from “FullTemplateName”, by BioRender.com (CurrentYear). Retrieved from https://app.biorender.com/biorender-templates